Irene Rombel discusses how artificial intelligence and machine learning can address bottlenecks, quality issues, and production costs in cell, gene, and RNA therapy manufacturing. The seminar focuses on real-world process-development applications that improve reproducibility, speed, and cost effectiveness.
We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.